As of 2024-12-15, the EV/EBITDA ratio of New Nordic Healthbrands AB (NNH.ST) is -19.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NNH.ST's latest enterprise value is 122.70 mil SEK. NNH.ST's TTM EBITDA according to its financial statements is -6.29 mil SEK. Dividing these 2 quantities gives us the above NNH.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 8.8x | 7.6x |
| Forward P/E multiples | 8.5x - 11.1x | 9.3x |
| Fair Price | (12.56) - 0.08 | (6.88) |
| Upside | -186.0% - -99.5% | -147.1% |
| Date | EV/EBITDA |
| 2024-12-09 | -19.90 |
| 2024-12-06 | -19.70 |
| 2024-12-05 | -19.99 |
| 2024-12-04 | -20.39 |
| 2024-12-03 | -20.49 |
| 2024-12-02 | -19.90 |
| 2024-11-29 | -19.80 |
| 2024-11-28 | -19.80 |
| 2024-11-27 | -19.60 |
| 2024-11-26 | -19.50 |
| 2024-11-25 | -20.49 |
| 2024-11-22 | -19.90 |
| 2024-11-19 | -19.90 |
| 2024-11-18 | -19.99 |
| 2024-11-15 | -20.29 |
| 2024-11-14 | -19.99 |
| 2024-11-13 | -19.99 |
| 2024-11-12 | -19.90 |
| 2024-11-11 | -20.49 |
| 2024-11-08 | -20.09 |
| 2024-11-07 | -20.49 |
| 2024-11-06 | -21.08 |
| 2024-11-05 | -20.68 |
| 2024-11-04 | -20.88 |
| 2024-11-01 | -21.18 |
| 2024-10-31 | -21.27 |
| 2024-10-30 | -22.85 |
| 2024-10-29 | -22.85 |
| 2024-10-28 | -22.85 |
| 2024-10-25 | -22.85 |
| 2024-10-24 | -22.85 |
| 2024-10-23 | -22.55 |
| 2024-10-22 | -21.86 |
| 2024-10-21 | -21.96 |
| 2024-10-18 | -21.37 |
| 2024-10-17 | -22.36 |
| 2024-10-16 | -21.96 |
| 2024-10-15 | -21.47 |
| 2024-10-14 | -20.88 |
| 2024-10-11 | -20.78 |
| 2024-10-07 | -20.88 |
| 2024-10-04 | -20.98 |
| 2024-10-02 | -20.68 |
| 2024-10-01 | -20.49 |
| 2024-09-30 | -20.19 |
| 2024-09-27 | -20.49 |
| 2024-09-26 | -20.68 |
| 2024-09-25 | -20.68 |
| 2024-09-24 | -21.08 |
| 2024-09-23 | -20.49 |